Asthma and Obstructive Sleep Apnea Relationship

Pathophysiological Mechanisms

Corticosteroid-induced weight gain represents a critical pathway where asthma treatment directly increases OSA risk, as systemic corticosteroids used for refractory asthma often lead to obesity, the principal risk factor for OSA, according to the American Thoracic Society 1

Gastroesophageal reflux disease is a shared risk factor for both asthma and OSA, as stated by the American Academy of Allergy, Asthma, and Immunology 2
Rhinitis and nasal obstruction are also shared risk factors, with the American Academy of Allergy, Asthma, and Immunology recommending evaluation for asthma in OSA patients with these conditions 3

The American Academy of Allergy, Asthma, and Immunology recommends screening all patients with moderate-to-severe or difficult-to-control asthma for OSA, particularly those who are overweight or obese 2
Significant weight gain, especially in those on systemic corticosteroids, is an indicator requiring OSA evaluation in asthmatic patients, as noted by the American Thoracic Society 1
Complaints of loud snoring, poor quality sleep, or excessive daytime sleepiness are also indicators for OSA evaluation, according to the American College of Chest Physicians 4

The American Academy of Sleep Medicine states that polysomnography remains the gold standard for diagnosing OSA in asthmatic patients, while home sleep studies may have higher false-negative rates and should be interpreted cautiously in this population 5

The American Thoracic Society suggests that treatment of OSA with CPAP may improve asthma symptoms in patients with both conditions, though the evidence is primarily observational 1
The American Academy of Allergy, Asthma, and Immunology recommends treatment of nasal obstruction and rhinitis to improve both conditions, including the use of intranasal corticosteroids to reduce nasal airway resistance and apnea-hypopnea frequency in patients with both OSA and rhinitis 3
Gastroesophageal reflux treatment should be considered, particularly in patients with frequent nighttime symptoms, using proton pump inhibitors and lifestyle modifications, as stated by the American Academy of Allergy, Asthma, and Immunology 2

Corticosteroid medications used to treat asthma may contribute to weight gain, which is the principal risk factor for OSA 6
The presence of OSA should be considered in patients with poorly controlled asthma, particularly those who are overweight or obese, as recommended by the American Academy of Allergy, Asthma, and Immunology 7, 8

Formal evaluation for OSA should be considered in children presenting with chronic rhinitis and other risk factors associated with sleep-disordered breathing, according to the American Academy of Allergy, Asthma, and Immunology 9
Polysomnography is the gold standard for diagnosing OSA in asthmatic patients, as stated by the American College of Chest Physicians 10
Weight management is crucial for patients with both asthma and OSA or at risk for OSA, as recommended by the American Thoracic Society 6
Treatment of nasal obstruction and rhinitis may improve both conditions, as suggested by the American Academy of Allergy, Asthma, and Immunology 9
Intranasal corticosteroids can reduce nasal airway resistance and apnea-hypopnea frequency in patients with both OSA and rhinitis, according to the American Academy of Otolaryngology 9